A new trading day began on Monday, with Quince Therapeutics Inc (NASDAQ: QNCX) stock price up 16.82% from the previous day of trading, before settling in for the closing price of $2.14. QNCX’s price has ranged from $0.72 to $2.45 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 7.53%. Meanwhile, its annual earnings per share averaged 16.54%. With a float of $48.06 million, this company’s outstanding shares have now reached $54.49 million.
Quince Therapeutics Inc (QNCX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Quince Therapeutics Inc is 13.69%, while institutional ownership is 20.78%.
Quince Therapeutics Inc (QNCX) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.28 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 16.54% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.83% during the next five years compared to 7.53% growth over the previous five years of trading.
Quince Therapeutics Inc (NASDAQ: QNCX) Trading Performance Indicators
Here are Quince Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.22, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Quince Therapeutics Inc (QNCX)
The latest stats from [Quince Therapeutics Inc, QNCX] show that its last 5-days average volume of 0.76 million was superior to 0.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 90.19%.
During the past 100 days, Quince Therapeutics Inc’s (QNCX) raw stochastic average was set at 84.13%, which indicates a significant increase from 84.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was higher than the 0.13 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.76, while its 200-day Moving Average is $1.49. Now, the first resistance to watch is $2.75. This is followed by the second major resistance level at $3.00. The third major resistance level sits at $3.30. If the price goes on to break the first support level at $2.20, it is likely to go to the next support level at $1.90. The third support level lies at $1.65 if the price breaches the second support level.
Quince Therapeutics Inc (NASDAQ: QNCX) Key Stats
With a market capitalization of 139.21 million, the company has a total of 55,681K Shares Outstanding. Currently, annual sales are 0 K while annual income is -56,830 K. The company’s previous quarter sales were 0 K while its latest quarter income was -13,440 K.
